Catalyst Wire Dossier Catalyst Wire Dossier

GK01

· Tianjin Medical University Cancer Institute and Hospital
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GK01, covering 2025-05-01 to 2026-01-20. Get the full timeline:

Most recent: Clinical Trial Update: A Single-arm, Open-label Study of GK01 in Combination With or Without Chemotherapy for the Adjuvant Treatment of Solid Tumors [Phase 1]

See pricing